95 related articles for article (PubMed ID: 1287745)
1. [Computer simulation of the 10-year outcome of a cohort of heroin addicts in Ile-de-France].
Charpak Y; Bejanin F
Rev Epidemiol Sante Publique; 1992; 40(6):454-9. PubMed ID: 1287745
[TBL] [Abstract][Full Text] [Related]
2. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
[TBL] [Abstract][Full Text] [Related]
4. [Mortality and HIV infection in a group of intravenous heroin addicts from 1985 to 1989].
Delvecchio G; Brancato V
Minerva Med; 1991 Oct; 82(10):675-8. PubMed ID: 1745378
[TBL] [Abstract][Full Text] [Related]
5. A 10-year follow-up study on the health status of heroin addicts based on official registers.
Sánchez-Carbonell X; Vilaregut A
Addiction; 2001 Dec; 96(12):1777-86. PubMed ID: 11784470
[TBL] [Abstract][Full Text] [Related]
6. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
Stoové MA; Dietze PM; Jolley D
Drug Alcohol Rev; 2009 Jul; 28(4):347-52. PubMed ID: 19594787
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
8. [Survival and mortality in a cohort of heroin addicts in 1985-1994].
Brancato V; Delvecchio G; Simone P
Minerva Med; 1995 Mar; 86(3):97-9. PubMed ID: 7603612
[TBL] [Abstract][Full Text] [Related]
9. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in HIV-infected heroin addicts: a multivariate analysis of nonspecific serological factors in the evolution of the infection].
Echániz P; Larrañaga P; Arrizabalaga J; Jiménez JL; Iribarren JA; Cuadrado E
Rev Clin Esp; 1992 May; 190(8):422-6. PubMed ID: 1620946
[TBL] [Abstract][Full Text] [Related]
11. [Cohort study methodology of the ITINERE Project on heroin users in three Spanish cities and main characteristics of the participants].
de la Fuente de Hoz L; Brugal Puig MT; Ballesta Gómez R; Bravo Poetela MJ; Barrio Anta G; Domingo Salvany A; Silva do Rosario T; Ambrós Hortensi M;
Rev Esp Salud Publica; 2005; 79(4):475-91. PubMed ID: 16465964
[TBL] [Abstract][Full Text] [Related]
12. Drug use and HIV/AIDS in China.
Liu Z; Lian Z; Zhao C
Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological aspects of drug addiction: morbidity and evaluation of care].
Facy F
Rev Prat; 1995 Jun; 45(11):1345-50. PubMed ID: 7659981
[TBL] [Abstract][Full Text] [Related]
14. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
Davoli M; Bargagli AM; Perucci CA; Schifano P; Belleudi V; Hickman M; Salamina G; Diecidue R; Vigna-Taglianti F; Faggiano F;
Addiction; 2007 Dec; 102(12):1954-9. PubMed ID: 18031430
[TBL] [Abstract][Full Text] [Related]
15. [Diseases in heroin addiction].
Merino F; Santamaría JM; Martínez M; Fernández J; Aizpiri J; San Cristóbal E; Subero Z; Esparza B
Invest Clin; 1989; 30(3):143-57. PubMed ID: 2489277
[TBL] [Abstract][Full Text] [Related]
16. [High prevalence of infection by hepatitis B virus and HIV in incarcerated French drug addicts].
Espinoza P; Bouchard I; Buffet C; Thiers V; Pillot J; Etienne JP
Gastroenterol Clin Biol; 1987 Apr; 11(4):288-92. PubMed ID: 3582884
[TBL] [Abstract][Full Text] [Related]
17. Preliminary findings of an epidemiological survey of drug addiction in Paris.
Ingold R; Olivenstein C
Bull Narc; 1983; 35(3):73-9. PubMed ID: 6561046
[TBL] [Abstract][Full Text] [Related]
18. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
[TBL] [Abstract][Full Text] [Related]
19. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
[TBL] [Abstract][Full Text] [Related]
20. [An 1-year prospective cohort study on mortality of injecting drug users].
Zhang L; Ruan YH; Jiang ZQ; Yang ZN; Liu SZ; Zhou F; He YX; Yin L; Qin GM; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Mar; 26(3):190-3. PubMed ID: 15941506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
